Updates on the Prevention and Treatment of Cancer-Related Infections
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Distinguish when to use prophylactic and empiric therapy in the treatment of infections to highlight factors that guide selection of drugs for treatment
Laura Zitella, RN, MS, ACNP-BC
Stanford Cancer Institute
- 0.50 Participation
- 0.54 Nurse
- 0.50 Pharmacist
- 0.50 Physician